HIGHLIGHTS
- who: Osteoporosis and collaborators from the University of Oxford, United Kingdom have published the article: Estradiol and zinc-doped nano hydroxyapatite as therapeutic agents in the prevention of osteoporosis; oxidative stress status, in fl ammation, bone turnover, bone mineral density, and histological alterations in ovariectomized rats, in the Journal: (JOURNAL)
- what: The aim of the study was to assess the prospective roles of nanoparticles of zinc-doped hydroxyapatite (ZnHA-NPs) to prevent or treat osteoporosis in comparison to E2 administration through the evaluation of serum bone turnover markers and oxidative/inflammatory responses, femoral expression of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.